160 related articles for article (PubMed ID: 36155168)
21. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
[TBL] [Abstract][Full Text] [Related]
22. Comparison of CT-based and MRI-based high-risk clinical target volumes in image guided-brachytherapy for cervical cancer, referencing recommendations from the Japanese Radiation Oncology Study Group (JROSG) and consensus statement guidelines from the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC ESTRO).
Iwai Y; Nemoto MW; Horikoshi T; Kanazawa A; Kurokawa M; Saito M; Harada R; Kobayashi H; Uno T
Jpn J Radiol; 2020 Sep; 38(9):899-905. PubMed ID: 32333219
[TBL] [Abstract][Full Text] [Related]
23. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
[TBL] [Abstract][Full Text] [Related]
24. Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome.
Choong ES; Bownes P; Musunuru HB; Rodda S; Richardson C; Al-Qaisieh B; Swift S; Orton J; Cooper R
Brachytherapy; 2016; 15(1):40-8. PubMed ID: 26602964
[TBL] [Abstract][Full Text] [Related]
25. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.
Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Fukushima Y; Hori M; Miura K; Takada Y; Nakata K; Sakata KI
J Radiat Res; 2020 Mar; 61(2):265-274. PubMed ID: 32009177
[TBL] [Abstract][Full Text] [Related]
26. Local Control of Squamous Cell Carcinoma of the Cervix Treated with CT-based Three-dimensional Image-Guided Brachytherapy with or without Central Shielding.
Yoshio K; Nagasaka H; Hisazumi K; Okawa H; Tajiri N; Shiode T; Akaki S; Kanazawa S; Mitoma T; Yano Y; Kobayashi E; Horiguchi I; Takata M; Hongo A; Yonezawa M; Nakanishi Y
Acta Med Okayama; 2021 Feb; 75(1):79-85. PubMed ID: 33649617
[TBL] [Abstract][Full Text] [Related]
27. Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer.
Wang Y; Ye WJ; Du LH; Li AJ; Ren YF; Cao XP
Chin J Cancer; 2012 Dec; 31(12):598-604. PubMed ID: 22640625
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study.
Otani Y; Ohno T; Ando K; Murata K; Kato S; Noda SE; Murofushi K; Ushijima H; Yoshida D; Okonogi N; Isohashi F; Wakatsuki M; Nakano T
J Radiat Res; 2021 May; 62(3):502-510. PubMed ID: 33532828
[TBL] [Abstract][Full Text] [Related]
29. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
[TBL] [Abstract][Full Text] [Related]
30. Image-guided brachytherapy following external-beam radiation therapy for patients with inoperable endometrial cancer.
Huang CH; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY; Chen SW
Brachytherapy; 2023; 22(1):72-79. PubMed ID: 36244907
[TBL] [Abstract][Full Text] [Related]
31. Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study.
Petric P; Lindegaard JC; Sturdza A; Fokdal L; Kirchheiner K; Tan LT; Schmid MP; Haie-Meder C; Jürgenliemk-Schulz IM; van Limbergen E; Hoskin P; Gillham C; Tharavichitkul E; Mahantshetty U; Villafranca E; Tanderup K; Kirisits C; Pötter R
Radiother Oncol; 2021 Apr; 157():24-31. PubMed ID: 33476724
[TBL] [Abstract][Full Text] [Related]
32. Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
Mahantshetty U; Krishnatry R; Hande V; Jamema S; Ghadi Y; Engineer R; Chopra S; Gurram L; Deshpande D; Shrviastava S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):608-617. PubMed ID: 29280456
[TBL] [Abstract][Full Text] [Related]
33. Dose-volume histogram parameters of high-dose-rate brachytherapy for Stage I-II cervical cancer (≤4cm) arising from a small-sized uterus treated with a point A dose-reduced plan.
Nakagawa A; Ohno T; Noda SE; Kubo N; Kuwako K; Saitoh J; Nakano T
J Radiat Res; 2014 Jul; 55(4):788-93. PubMed ID: 24566721
[TBL] [Abstract][Full Text] [Related]
34. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
35. Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based Brachytherapy for Cervical Cancer.
Aoshika T; Noda SE; Abe T; Kumazaki YU; Hirai R; Igari M; Saito S; Ryuno Y; Iino M; Takeda Y; Ohta T; Watanabe J; Tsukahara K; Kato S
Anticancer Res; 2024 Apr; 44(4):1583-1589. PubMed ID: 38537975
[TBL] [Abstract][Full Text] [Related]
36. Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients.
Kusada T; Toita T; Ariga T; Kudaka W; Maemoto H; Makino W; Ishikawa K; Heianna J; Nagai Y; Aoki Y; Murayama S
Int J Clin Oncol; 2020 Nov; 25(11):1977-1984. PubMed ID: 32852648
[TBL] [Abstract][Full Text] [Related]
37. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
[TBL] [Abstract][Full Text] [Related]
38. A retrospective study of small-pelvis radiotherapy plus image-guided brachytherapy in stage I-II non-bulky cervical squamous cell carcinoma.
Yoshimoto Y; Murata K; Irie D; Ando K; Adachi A; Aoki H; Hirakawa T; Noda SE; Nakano T; Ohno T
J Radiat Res; 2022 Mar; 63(2):290-295. PubMed ID: 35152292
[TBL] [Abstract][Full Text] [Related]
39. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
[TBL] [Abstract][Full Text] [Related]
40. A retrospective study of locally advanced cervical cancer cases treated with CT-based 3D-IGBT compared with 2D-IGBT.
Kinoshita T; Takahashi S; Anada M; Nishide T; Kanenishi K; Kawada A; Shibata T
Jpn J Radiol; 2023 Oct; 41(10):1164-1172. PubMed ID: 37140821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
